Skip to content Skip to navigation

Phenomics Lab

High-throughput solutions for large-scale disease phenotyping.

We have established scalable, high-throughput phenotyping methods for characterizing human and mouse eye diseases. The mouse eye phenotype screening service is available to laboratories throughout the world. Through the development of cooperative laboratory networks, we hope to expand our screening effort.

Projects

We have established a scalable, multilevel, high-throughput phenotyping laboratory to identify mouse models for eye disease.

Capturing surgical events for careful clinical studies has always been a challenge.

News

Sep 30 2021 | Posted In: 20/20 Blog
 
Jul 6 2021 | Posted In: 20/20 Blog
Palo Alto, CA – As genetic testing and molecular biomarkers open new avenues for medical care, researchers are more reliant on samples from human subjects than ever.
Aug 19 2020 | Posted In: 20/20 Blog
Palo Alto, CA — Retinal detachment surgery is an emergency procedure that prevents blindness, but research from Stanford’s Byers Eye Institute shows women may be treated differently than men.
Jun 15 2020 | Posted In: 20/20 Blog
Palo Alto, CA — Despite the near complete shutdown of in-person laboratory activities at the beginning of the COVID-19 pandemic, the Stanford Ophthalmology research laboratories remain incredibly productive.
Jun 8 2020 | Posted In: 20/20 Blog, Press
Palo Alto, Ca — Genetic testing doesn’t always provide a diagnosis, so Vinit Mahajan M.D., Ph.D., professor of ophthalmology at Stanford University, has applied proteomics to better understand disease in his patients. 
See more news

Publications

Fundoscopy-directed genetic testing to re-evaluate negative whole exome sequencing results., Cho, Ahra, de Carvalho Jose Ronaldo Li, Tanaka Akemi J., Jauregui Ruben, Levi Sarah R., Bassuk Alexander G., Mahajan Vinit B., and Tsang Stephen H. , Orphanet J Rare Dis, 2020 Jan 30, Volume 15, Issue 1, p.32, (2020)
Modulation of Post-Traumatic Immune Response Using the IL-1 Receptor Antagonist Anakinra for Improved Visual Outcomes., Evans, Lucy P., Woll Addison W., Wu Shu, Todd Brittany P., Hehr Nicole, Hedberg-Buenz Adam, Anderson Michael G., Newell Elizabeth A., Ferguson Polly J., Mahajan Vinit B., et al. , J Neurotrauma, 2020 Mar 16, (2020)
Sex Does Not Influence Visual Outcomes After Blast-Mediated Traumatic Brain Injury but IL-1 Pathway Mutations Confer Partial Rescue., Evans, Lucy P., Boehme Nickolas, Wu Shu, Burghardt Elliot L., Akurathi Abhigna, Todd Brittany P., Newell Elizabeth A., Ferguson Polly J., Mahajan Vinit B., Dutca Laura M., et al. , Invest Ophthalmol Vis Sci, 2020 Oct 01, Volume 61, Issue 12, p.7, (2020)
Phenotypic variance in Calpain-5 retinal degeneration., Tang, Peter H., Chemudupati Teja, Wert Katherine J., Folk James C., Mahajan Maryann, Tsang Stephen H., Bassuk Alexander G., and Mahajan Vinit B. , Am J Ophthalmol Case Rep, 2020 Jun, Volume 18, p.100627, (2020)
Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis., Park, Jong G., Callaway Natalia F., Ludwig Cassie A., and Mahajan Vinit B. , Am J Ophthalmol Case Rep, 2020 Sep, Volume 19, p.100859, (2020)
Proteomic analysis of intermediate uveitis suggests myeloid cell recruitment and implicates IL-23 as a therapeutic target., Sepah, Yasir J., Velez Gabriel, Tang Peter H., Yang Jing, Chemudupati Teja, Li Angela S., Nguyen Quan D., Bassuk Alexander G., and Mahajan Vinit B. , Am J Ophthalmol Case Rep, 2020 Jun, Volume 18, p.100646, (2020)
See more publications